DUBLIN--(BUSINESS WIRE)--HiberGene Diagnostics, a company focused on the application of molecular technology to infectious disease testing, has raised a first tranche of €1.5 million as part of a total Series B fundraising of approximately €3.5 million.
The €1.5 million comes from a number of undisclosed private investors in Ireland, and was mainly raised through the Irish Employment and Investment Incentive (EII) scheme.
